Artificial Intelligence In Drug Discovery Market Is Driving Innovation By Reducing Drug Discovery Timelines
Artificial Intelligence In Drug Discovery Market Artificial intelligence in drug discovery involves leveraging machine learning, deep learning, and other artificial intelligence techniques to help streamline the drug discovery process. AI has shown immense potential to analyze huge amounts of chemical, biological and clinical data to help identify new drug candidates. With AI, researchers can screen millions of potential drug compounds in silico and focus only on the most promising candidates, reducing costly late-stage clinical trial failures. Some key advantages of AI in drug discovery include evaluating a larger chemical space, predicting toxicity, accelerating target identification, and enhancing the precision of preclinical research. The Global Artificial Intelligence in Drug Discovery Market is estimated to be valued at US$ 1459.24 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031. Key Takeaways Key players: Key players operating...